When a doctor gives you a prescription, you assume the medicine the doctor prescribed is approved for the problem you have. While this is normally true, sometimes doctors are persuaded to prescribe drugs for uses that the drug has not been approved for. Such a case has been alleged against Johnson & Johnson the maker of Risperdal according to the New Jersey Real Time News.
Johnson & Johnson is one of the world’s largest health product companies in the world. One of its most popular drugs, Risperdal, was once one of its best selling drugs reaching $24.2 billion dollars in sales from 2003 to 2010.
The problem arose when the Food and Drug Administration, which approves medications, only approved Risperdal for certain psychotic disorders including schizophrenia. Unfortunately that is a very limited market.
The United States Government alleges that Johnson & Johnson began to try and sell Risperdal for by-polar disorder, dementia, mood and anxiety disorders and other unapproved uses. The U.S. Government has been investigating Risperdal sales practices since 2004. The State of Louisiana conducted an investigation into Johnson & Johnson sales practices in Louisiana and ultimately filed suit claiming sales people sold Risperdal to doctors, nursing homes, veterans’ administration facilities and jails for uses that the drug had not been approved for.
Currently Johnson & Johnson has agreed to pay $1 billion dollars to the United States and hopefully to most of the states involved in civil investigations into marketing the anti-psychotic drug Risperdal. The State of Texas filed a separate law suit against Johnson & Johnson that is set for trial in 2012. If you have questions about dangerous drugs, unsafe products or in other personal injury matter contact us, we help.